Status:

COMPLETED

Artemether-Lumefantrine Effectiveness in Guinea-Bissau

Lead Sponsor:

Bandim Health Project

Conditions:

Malaria

Eligibility:

All Genders

Up to 15 years

Brief Summary

The routine treatment of children with antimalarials will be monitored. Children with a positive malaria film and/or a positive rapid diagnostic test (RDT) will be included in a follow-up study. The g...

Detailed Description

Children from the Bandim area in Bissau who are seeking medical advice and who are recommended treatment for malaria in accordance with the current routines will be included as follows: All children ...

Eligibility Criteria

Inclusion

  • Prescribed an anti-malarial at the Bandim Health Centre
  • Having P. falciparum parasites in a thick film and/or a positive RDT
  • The Bandim address is known (to enable follow up).

Exclusion

  • Children where the parents do not accept to participate in the study.
  • Signs of severe malaria such as convulsion or severe anemia

Key Trial Info

Start Date :

March 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2016

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT01157689

Start Date

March 1 2010

End Date

June 1 2016

Last Update

May 19 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Bandim Health Project

Bissau, Bissau Codex, Guinea-Bissau, 1004

Artemether-Lumefantrine Effectiveness in Guinea-Bissau | DecenTrialz